Clinical Trials Browser

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT07185672 2025-09-22

PReCedeNT

Phase 3 Recruiting

162 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05387603 2025-09-10

START-NET

Phase 3 Recruiting

300 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

166 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06091748 2025-06-03

Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

Phase 3 Recruiting

66 enrolled

EndocrineGastrointestinalNET

Advanced Gastroenteropancreatic Neuroendocrine Tumor

NCT06791005 2025-01-24

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Phase 3 Recruiting

400 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT04847505 2024-07-18

68Ga-DOTA-TATE PET/CT Imaging in NETs

Phase 3 Recruiting

5,000 enrolled

EndocrineNET

Neuroendocrine Tumors

Clinical Trials

CAREFNDR

LEVEL

NETTER-3

TARLANEC

18F-DOPA II - PET Imaging Optimization

ACTION-1

Tumor HI

PReCedeNT

START-NET

RIALTO

Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

68Ga-DOTA-TATE PET/CT Imaging in NETs